about
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserveBone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research networkClinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomesA population-based evaluation of the thrombolysis in myocardial infarction risk score for unstable angina and non-ST elevation myocardial infarctionUse of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).Aortic flow conditions predict ejection efficiency in the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE).The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease.Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRNPredictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertensionDepression, dietary habits, and cardiovascular events among women with suspected myocardial ischemia2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations.Gut dysbiosis is linked to hypertension.A training program in cardiovascular cell-based therapy: from the NHLBI Cardiovascular Cell Therapy Research Network.Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST)Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women's ischemia Syndrome Evaluation (WISE) Study.Enhancing the function of CD34(+) cells by targeting plasminogen activator inhibitor-1Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)Microvascular coronary dysfunction and ischemic heart disease: where are we in 2014?Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation.Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia.Commentary on "new and emerging theories of cardiovascular disease".Ischemic heart disease: metabolic approaches to management.Cardiovascular therapies and risk for development of diabetes.Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics.Education: nationally achievable solutions.Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic CardiomyopathyHypertension-Linked Pathophysiological Alterations in the Gut.Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD.Acetylcholine versus cold pressor testing for evaluation of coronary endothelial functionRelationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation StudyAssociation of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome EvaluatioAngina treatments and prevention of cardiac events: an appraisal of the evidence
P50
Q26776330-AF117E96-F567-4454-A368-43277B2D0FB4Q26821783-EC71D324-9394-4240-9B1F-43EC3279CDD2Q26861338-29ABB8F5-16E6-4C58-9ED3-C34A6D878B7BQ28167379-4333D212-CC8C-4F55-B821-B7D205AF4FBDQ31137035-3682BB42-F8EF-4A34-9946-8D31D8F0A40BQ33707885-5E5ED765-F41A-480F-AABE-B29DE80BF2AEQ33714666-A35017F3-B467-4F61-A4C9-1ED423A93BC1Q33748399-F4D2A30E-C67C-4A46-97DC-207122411BECQ33841979-693A173E-F2FF-422C-90E9-8D02E60E4183Q33981146-695FD8E7-9CFA-48E3-9886-145E2F0502DFQ33987980-47D21D13-4915-4F8D-8860-C2417B49E9A5Q34167482-705B7E50-87FE-4592-8C7F-FB55148F4484Q34321437-63398464-7CFB-48C5-A7F1-A2BDFDBEBC94Q34565643-136237DE-7106-43B3-B524-D8B40C7E5948Q34669297-A1D48CA1-1B27-4BF9-86B9-DC01FC90F56AQ34729459-800867D2-034A-4A0C-83EC-51B746BE1202Q34747258-A7CAAD2E-1A3E-4B1E-95BF-5A2C16A2DE1DQ34807168-0C4E96B9-FA44-4490-BB7A-42F4A6F9F521Q34994772-722966D4-AE84-494E-ABB6-EE963328B367Q35041129-52D64B65-D2A4-4D57-8DA7-66F6E98C4BBDQ35061266-BAE86484-7F8C-4B22-A1D5-D0DA7656B944Q35108848-9AC89EFD-965E-4FEF-976F-B5225EC5BCA0Q35115111-F5D13D08-C5A9-469B-99A6-F4E0CB71997DQ35141989-A4F2FE40-9DF0-4083-8D91-2F433DB2815CQ35174462-A271025F-FA9B-4F9D-BB5C-D12D85F86116Q35222305-111FA462-E9E2-4889-8C23-6FB3A0A66FE3Q35581383-78798CF3-5873-42DB-9F63-8E3D4B53D66DQ35798454-88468484-8460-405A-8E13-DF6317E602C5Q35878082-7E354C96-293E-4D30-AC0B-0531D9157269Q35882983-4F0E2A52-D44F-49A3-B99D-C8A69BC5694FQ35990719-F96F8BB2-E2E3-4896-B9A7-9C5613CDA59DQ36039077-6E2038D2-28A1-4961-A62D-5A5E2D924B2EQ36108754-14493B08-89E5-43C1-99F8-67C4C2B0931EQ36178777-67EF052B-A782-491A-BD32-63C1BA651257Q36202061-ABC4F4DC-4D5E-4124-A3DB-379EE7BF2D94Q36247712-B21E3CE2-6310-461D-A769-868E80610EB3Q36282922-5E24E137-0AF6-4E86-86C3-C1019EE4633DQ36351005-6D4AFF39-A2BD-43E5-8E2B-352BFD122C3EQ36389912-4982E732-45CC-45D2-8092-B80E07DF5E7BQ36429293-BF9FBA20-5C3F-49D8-8620-A80868E8C721
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carl J Pepine
@ast
Carl J Pepine
@en
Carl J Pepine
@es
Carl J Pepine
@nl
type
label
Carl J Pepine
@ast
Carl J Pepine
@en
Carl J Pepine
@es
Carl J Pepine
@nl
prefLabel
Carl J Pepine
@ast
Carl J Pepine
@en
Carl J Pepine
@es
Carl J Pepine
@nl
P106
P31
P496
0000-0002-6011-681X